The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
28111141 |
58 |
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics. |
Merck |
28105264 |
6 |
Potential of Renal Outer Medullary Potassium (ROMK) Channel as Treatments for Hypertension and Heart Failure. |
Therachem Research Medilab (India) |
27839686 |
65 |
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold. |
Merck Research Laboratories |
27190590 |
11 |
Inhibitors of Renal Outer Medullary Potassium Channel. |
Temple University |
27017115 |
77 |
Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation. |
Merck Research Laboratories |
26288678 |
12 |
Inhibitors of the Renal Outer Medullary Potassium Channel. |
Temple University |
26191360 |
99 |
Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation. |
Merck Research Laboratories |
24075732 |
43 |
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one. |
Merck Research Laboratories |
24900480 |
75 |
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics. |
TBA |
27437080 |
96 |
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure. |
Merck Research Laboratories |
31034224 |
24 |
Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics. |
University of Nebraska Medical Center |
29456800 |
47 |
Discovery and in Vitro Optimization of 3-Sulfamoylbenzamides as ROMK Inhibitors. |
Pfizer |
28431879 |
123 |
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores. |
Merck |
26833890 |
18 |
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease. |
Yogi Vemana University |
26469307 |
7 |
Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b. |
University of Leipzig |
17620441 |
5 |
Novel antagonists of the thioesterase domain of human fatty acid synthase. |
Burnham Institute For Medical Research |
11196150 |
3 |
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. |
Janssen Research Foundation |
14592500 |
29 |
Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavir. |
Merck Research Laboratories |